Matthew Elliott - Concepedia

Author

Matthew Elliott

University of Dundee ORCID

Also Known As

M. Elliott, Matthew ELLIOTT, Matthew Elliott, Matthew V Elliott, Matthew V. Elliott, Matthew Vensano-Elliott

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of Dundee MRC Protein Phosphorylation and Ubiquitylation Unit University of Padua Veneto Institute of Molecular Medicine Polish Academy of Sciences

About

Matthew Elliott is an author at University of Dundee specializing in medicine, cell biology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.3K
2	Natural Sciences	6	6	967
3	Education	1	1	60
4	Engineering	1	1	237
5	Social Sciences	1	1	60

Matthew Elliott

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
The specificities of protein kinase inhibitors: an update Jenny Bain, Hilary McLauchlan, Matthew Elliott, Biochemical Journal	2003	1.4K
D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a Graham Rena, Jenny Bain, Matthew Elliott, EMBO Reports Transcriptional RegulationSignal TransductionSignaling PathwayCell RegulationMolecular Regulation	2004	250
The selectivity of inhibitors of protein kinase CK2: an update Mario A. Pagano, Jenny Bain, Zygmunt Kazimierczuk, Biochemical Journal Chemoprevention StrategyProtein Kinase Ck2PathologySelectivity Towards Ck2Tumor Biology	2008	240
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research Suzannah J. Rihn, Andres Merits, Siddharth Bakshi, PLoS Biology EngineeringGeneticsImmunologyViral PathogenesisCovid-19 Epidemiology	2021	237
Optimization of Protein Kinase CK2 Inhibitors Derived from 4,5,6,7-Tetrabromobenzimidazole Mario A. Pagano, Mariola Andrzejewska, Maria Ruzzene, Journal of Medicinal Chemistry	2004	184
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 Giorgio Cozza, Marco Mazzorana, E. Papinutto, Biochemical Journal Medicinal ChemistryVirtual ScreeningChemoprevention StrategyBiochemistryProtein Kinase Ck2	2009	158
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA) Stefania Sarno, E. De Moliner, Maria Ruzzene, Biochemical Journal	2003	138
Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors Mario A. Pagano, Giorgia Poletto, Giovanni Di Maira, ChemBioChem Bioorganic ChemistryChemoprevention StrategyProtein Kinase Ck2Chemical BiologyPharmaceutical Chemistry	2006	126
Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition David Komander, Gursant Kular, Jennifer Bain, Biochemical Journal Proteinlipid InteractionMolecular BiologyPdk1 Active SiteChemical BiologySignaling Pathway	2003	113
Inhibition of Protein Kinase CK2 by Condensed Polyphenolic Derivatives. An in Vitro and in Vivo Study Flavio Meggio, Mario A. Pagano, Stefano Moro, Biochemistry	2004	90

Page 1